EirGenix Profit Margin

EirGenix (6589.TW) currently reports a profit margin of -65.89% as of March 2026. That compares with -77.37% in the prior-year period — up 14.8% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore EirGenix's profit margin history and peer comparisons.

EirGenix's profit margin increased from -77.37% to -65.89% — a 14.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

EirGenix's profit margin of -65.89% is lower than the Healthcare sector average of 9.48%. That is roughly 795.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but EirGenix's current -65.89% should be judged against Healthcare norms (sector average: 9.48%) and against 6589.TW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -65.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for EirGenix, and consider following 6589.TW for alerts when major investors trade the stock.